MedPath

Optimized Perioperative Analgesia Reduces the Prevalence and the Intensity of Phantom Pain in Lower Limb Amputation

Phase 2
Completed
Conditions
Phantom Limb Pain
Interventions
Procedure: perioperative epidural catheter
Registration Number
NCT00443404
Lead Sponsor
University of Patras
Brief Summary

Severe pre-amputation pain is associated with phantom pain development, and phantom pain models assign major importance to central and peripheral nervous system changes related to pre-amputation pain. Several interventions have been evaluated for phantom pain prevention, including continuous brachial plexus blockade5, intravenous6 or epidural ketamine administration, postoperative perineural ketamine/clonidine infusion8 and oral gabapentin9, but their true effect remains unclear.

Detailed Description

In a prospective, randomized, double-blind trial, 65 patients undergoing elective lower limb amputation were assigned to one of five analgesic regimens. Patients in groups 1-4 had lumbar epidural catheter placed 48 hours before amputation, and received epidural bupivacaine/fentanyl or saline infusion before and/or after amputation. Patients receiving epidural saline also had IV Fentanyl Patient-Control Analgesia, whereas patients receiving epidural analgesia also had IV saline. Group 5 (control) received IM meperidine and oral codeine/acetaminophen. VAS and McGill Pain Questionnaire (MPQ) scores (for ischemic, phantom and stump pain) were recorded starting 48 hours before, continuing until 48 hours after amputation, and at 4 days, 10 days, 1 and 6 months after amputation. Phantom and stump pain intensity and frequency were the main study endpoints.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Age >18, Visual Analog. Scale (VAS) pain score >70mm which was frequent or continuous one week before scheduled major (above or below knee) amputation, and patient consent.
Exclusion Criteria
  • No written patient consent
  • Age < 18 years
  • Age > 82 years
  • Antiplatelet medication
  • Mental status not acceptable
  • Exclusion criteria were age >85
  • Emergency amputation
  • Ipsilateral re-amputation
  • Foot or toe amputation
  • Inability to complete a detailed pain questionnaire
  • History of chronic pain or substance abuse
  • Active psychiatric disease requiring treatment
  • Any contraindication to epidural catheter placement (anticoagulation, anti-platelet medications, previous lumbar spine surgery).

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
2perioperative epidural catheterIv PCA Fentanyl preoperative, Epidural analgesia postoperative
3perioperative epidural catheterperioperative IV PCA Fentanyl, epidural anesthesia
1perioperative epidural catheterperioperative epidural analgesia
5perioperative epidural catheterIV PCA with saline 0.9% and sc saline 0.9%in the L3-L4 area. IM meperidine, po codeine/acetaminophen, IV acetaminophen and IV parecoxib
4perioperative epidural catheterperioperative IV PCA Fentanyl general anesthesia
Primary Outcome Measures
NameTimeMethod
VAS and McGill PRI(R)2 scores for phantom and stump pain are recorded 48 and 24 hours before, and 4 and 10 days, 1 and 6 months after amputation. Phantom and stump pain intensity are the endpoints of the study.six months
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath